Literature DB >> 21127828

[Stocked medications in emergency physician-based medical services in Germany. Reality and requirements according to guidelines].

D Rörtgen1, A Schaumberg, M Skorning, S Bergrath, S K Beckers, M Coburn, J C Brokmann, H Fischermann, M Nieveler, R Rossaint.   

Abstract

BACKGROUND: The emergency medical service (EMS) should work according to criteria of evidence-based medicine. In Germany the EMS of each state is under the control of at least one medical supervisor known as emergency medical directors (EMD) and most states have several different EMDs responsible for one or more provinces of the state. The German Medical Association advises these supervisors to specify the pharmacological resources in store for use in physician powered EMSs. This study examines the pharmacological resources in EMSs which is provided by the EMDs in Germany. Furthermore, a comparison of the inventory analysis of stored drugs was carried out with the requirements according to guidelines for selected tracer diagnoses.
METHOD: In the period of May 2008 to January 2009 a total of 148 EMDs were contacted and asked to supply drug storage lists for emergency physician-staffed rescue vehicles in their respective jurisdiction. The addresses of all EMDs who could be identified by the federal office of the National Association of Emergency Medical Director, Germany were used over the period. The evaluation was conducted anonymously. The tracer diagnoses "cardiopulmonary resuscitation", "acute coronary syndrome", "status generalized tonic-clonic seizure," "severe asthma attack", "acute exacerbation of chronic obstructive pulmonary disease", "supraventricular tachycardia", "severe brain trauma" and "acute heart failure with signs of hypoperfusion" were selected. Current and established guidelines have been identified with the homepage of the Scientific Medical Societies in Germany and supported by the leading European and International guidelines.
RESULTS: The corresponding lists were returned by 95 different emergency service areas (response rate 64.2%). With a total of 39 groups of substances 142 different drugs could be identified, an average of 54±9.6 and median 55 (range 31-77). Listed are agents giving the provision in percent, for which the comparison with guidelines for tracer diagnoses could show deficits: sodium bicarbonate 75.8%, calcium 50.5%, magnesium 45.3%, noradrenaline 65.3%, adenosine 58.9%, dobutamine 57.9%, lorazepam iv 13.7%, salbutamol 41.1%, ipratropium bromide 13.7% (the last two as liquid preparations for inhalation). With a frequency of about 30-80%, depending on the respective tracer diagnosis, no medical emergency treatment according to the highest level of evidence is possible.
CONCLUSION: Due to recent treatment recommendations provision with sodium bicarbonate, calcium, magnesium, noradrenaline, adenosine, lorazepam iv, dobutamine and as well with ipratropium bromide and salbutamol (both as liquid preparations for inhalation) should be improved. For the future, a federal uniform minimum standard due to evidence-based principles is desirable.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21127828     DOI: 10.1007/s00101-010-1812-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  30 in total

1.  [Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations].

Authors:  C W Hamm
Journal:  Z Kardiol       Date:  2004-01

2.  Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

Authors:  Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos S Filippatos; Guillaume Jondeau; Yonathan Hasin; José Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin R Cowie; Veronica Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; Maria Angeles Alonso Garcia; Kenneth Dickstein; Anibal Albuquerque; Pedro Conthe; Maria Crespo-Leiro; Roberto Ferrari; Ferenc Follath; Antonello Gavazzi; Uwe Janssens; Michel Komajda; João Morais; Rui Moreno; Mervyn Singer; Satish Singh; Michal Tendera; Kristian Thygesen
Journal:  Eur Heart J       Date:  2005-01-28       Impact factor: 29.983

Review 3.  European Resuscitation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support.

Authors:  Jerry P Nolan; Charles D Deakin; Jasmeet Soar; Bernd W Böttiger; Gary Smith
Journal:  Resuscitation       Date:  2005-12       Impact factor: 5.262

Review 4.  [Evidence based guidelines and clinical pathways: complementation or contradiction?].

Authors:  M Lelgemann; G Ollenschläger
Journal:  Internist (Berl)       Date:  2006-07       Impact factor: 0.743

5.  Realistic assessment of the physician-staffed emergency services in Germany.

Authors:  A Gries; W Zink; M Bernhard; M Messelken; T Schlechtriemen
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

Review 6.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur J Heart Fail       Date:  2008-09-16       Impact factor: 15.534

7.  First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.

Authors:  G J Rodrigo; C Rodrigo
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

8.  Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II).

Authors:  A M Ross; P Molhoek; C Lundergan; M Knudtson; Y Draoui; L Regalado; V Le Louer; F Bigonzi; W Schwartz; E de Jong; K Coyne
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

9.  The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina.

Authors:  Caroline Daly; Felicity Clemens; Jose L Lopez-Sendon; Luigi Tavazzi; Eric Boersma; Nicholas Danchin; Francois Delahaye; Anselm Gitt; Desmond Julian; David Mulcahy; Witold Ruzyllo; Kristian Thygesen; Freek Verheugt; Kim M Fox
Journal:  Eur Heart J       Date:  2006-05-16       Impact factor: 29.983

10.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

View more
  9 in total

Review 1.  [Tele-emergency physician : New care concept in emergency medicine].

Authors:  Viola Koncz; Thorsten Kohlmann; Stefan Bielmeier; Bert Urban; Stephan Prückner
Journal:  Unfallchirurg       Date:  2019-09       Impact factor: 1.000

2.  [Potential and effectiveness of a telemedical rescue assistance system. Prospective observational study on implementation in emergency medicine].

Authors:  J C Brokmann; R Rossaint; S Bergrath; B Valentin; S K Beckers; F Hirsch; S Jeschke; M Czaplik
Journal:  Anaesthesist       Date:  2015-06-03       Impact factor: 1.041

3.  [Preclinical emergency anesthesia : A current state analysis from 2015-2017].

Authors:  A Luckscheiter; T Lohs; M Fischer; W Zink
Journal:  Anaesthesist       Date:  2019-03-18       Impact factor: 1.041

Review 4.  [Psychotropic agents in emergency medicine].

Authors:  A Wolf; M J Müller; F-G B Pajonk
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-02       Impact factor: 0.840

5.  [Different levels of experience with anesthetic agents of German emergency physicians : Results of an online survey].

Authors:  A Luckscheiter; M Fischer; W Zink
Journal:  Anaesthesist       Date:  2017-12-05       Impact factor: 1.041

6.  [Comparison of sublingual and intravenous administration of lorazepam in psychiatric emergencies in emergency medical services].

Authors:  D Schwerthöffer; F-G Pajonk
Journal:  Anaesthesist       Date:  2018-12-06       Impact factor: 1.041

Review 7.  [Pharmacotherapy of psychiatric acute and emergency situations: General principles].

Authors:  T Messer; F-G Pajonk; M J Müller
Journal:  Nervenarzt       Date:  2015-09       Impact factor: 1.214

8.  [Stocked medications in emergency medical service vehicles staffed by physicians-is prehospital treatment according to current guidelines possible?]

Authors:  Eike Carstens; Hendrik Eismann; Markus Flentje; Thomas Albers; Lion Sieg
Journal:  Notf Rett Med       Date:  2022-05-13       Impact factor: 0.892

Review 9.  [Rocuronium and sugammadex in emergency medicine: requirements of a muscle relaxant for rapid sequence induction].

Authors:  J Luxen; H Trentzsch; B Urban
Journal:  Anaesthesist       Date:  2014-04       Impact factor: 1.041

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.